Tag: Orange Book
Paragraph IV Certifications: How Generic Drug Companies Challenge Patents Before Market Entry
Paragraph IV certifications let generic drugmakers challenge brand-name patents before launch, speeding up cheaper alternatives. This legal tool under the Hatch-Waxman Act has saved consumers trillions and reshaped pharmaceutical competition.